ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

IMRX vs QTTB // ENTERPRISE SCALE & MARKET CAP

Immuneering Corporation (Class A) (NASDAQ) VS. Q32 Bio Inc. (NASDAQ) • 15-METRIC TALLY: IMRX 0 — QTTB 5
▲ ENTERPRISE SCALE & MARKET CAP LEADER: QTTB
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IMRX VS. QTTB) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC IMRX QTTB SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 85.00% -120.00 QTTB /roic <GO>
EV/EBITDA & P/E Valuation — 12.8x — TIE /valuation <GO>
Free Cash Flow Yield -17.49% -12.70% -4.79 QTTB /fcf-yield <GO>
Operating Margin — 31.50% — TIE /operating-margins <GO>
Net Profit Margin — 55.50% — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 5.99 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 4/9 -1.00 QTTB /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 43.1 48.1 -4.99 QTTB /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 8.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $260.1M $264.1M -$4.0M QTTB /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR IMRX REV QTTB REV IMRX GROSS % QTTB GROSS % IMRX FCF QTTB FCF
FY 2025 $0 $53.7M — — -$45.5M -$33.5M
FY 2024 $0 $0 — — -$55.1M -$67.8M
FY 2023 $0 $1.2M — — -$49.0M -$18.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IMRX // BETA —
QTTB // BETA —